BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32918837)

  • 1. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
    J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
    Ziegler D; Tesfaye S; Spallone V; Gurieva I; Al Kaabi J; Mankovsky B; Martinka E; Radulian G; Nguyen KT; Stirban AO; Tankova T; Varkonyi T; Freeman R; Kempler P; Boulton AJ
    Diabetes Res Clin Pract; 2022 Apr; 186():109063. PubMed ID: 34547367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic polyneuropathy].
    Ziegler D
    Internist (Berl); 2020 Mar; 61(3):243-253. PubMed ID: 32086529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic treatments for diabetic peripheral neuropathy.
    Ziegler D
    Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy.
    Bönhof GJ; Herder C; Ziegler D
    Curr Diabetes Rev; 2022; 18(5):e120421192781. PubMed ID: 33845748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D
    Curr Diabetes Rev; 2011 May; 7(3):208-20. PubMed ID: 21534920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
    Sloan G; Selvarajah D; Tesfaye S
    Nat Rev Endocrinol; 2021 Jul; 17(7):400-420. PubMed ID: 34050323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy.
    McIlduff CE; Rutkove SB
    Ther Clin Risk Manag; 2011; 7():377-85. PubMed ID: 21941444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review.
    Ardeleanu V; Toma A; Pafili K; Papanas N; Motofei I; Diaconu CC; Rizzo M; Stoian AP
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936646
    [No Abstract]   [Full Text] [Related]  

  • 10. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN).
    Sharma S; Rayman G
    Front Endocrinol (Lausanne); 2023; 14():1165505. PubMed ID: 37274325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whither pathogenetic treatments for diabetic polyneuropathy?
    Boulton AJ; Kempler P; Ametov A; Ziegler D
    Diabetes Metab Res Rev; 2013 Jul; 29(5):327-33. PubMed ID: 23381942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathic pain is not adequately treated in the older general population: Results from the KORA F4 survey.
    Meisinger C; Bongaerts BWC; Heier M; Amann U; Kowall B; Herder C; Rückert-Eheberg IM; Rathmann W; Ziegler D
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):806-814. PubMed ID: 29797371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.
    Tesfaye S; Boulton AJ; Dickenson AH
    Diabetes Care; 2013 Sep; 36(9):2456-65. PubMed ID: 23970715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy.
    Kasznicki J
    Arch Med Sci; 2014 May; 10(2):345-54. PubMed ID: 24904671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diabetic polyneuropathy: Update 2006.
    Ziegler D
    Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burning through the pain: treatments for diabetic neuropathy.
    Javed S; Alam U; Malik RA
    Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways in the diagnosis and management of diabetic polyneuropathy.
    Kaku M; Vinik A; Simpson DM
    Curr Diab Rep; 2015 Jun; 15(6):609. PubMed ID: 25899758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.